ABCD-10与SCORTEN在SJS/TEN死亡预测中的表现比较
该回顾性研究纳入2009至2019年北卡罗来纳Jaycee烧伤中心收治的192例SJS/TEN患者,总体死亡率为22%(n=43)。作者认为在该北美三级烧伤中心队列中SCORTEN优于ABCD-10。
要点
- 两模型区分度均良好,但样本量小限制了结论强度。
核心结论
- 在该北美三级烧伤中心SJS/TEN队列中,SCORTEN对住院死亡的预测优于ABCD-10。
研究设计与样本
- 采用单因素logistic回归与Hosmer-Lemeshow检验评估两种死亡预测模型的表现。
主要发现
- 总体死亡率为22%(n=43)。
- 两模型均显示良好区分度。
临床怎么用
- 在SJS/TEN住院死亡风险预测中可优先考虑SCORTEN,ABCD-10在该人群的校准欠佳。
局限性
- 样本量小。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Age, bicarbonate, cancer, dialysis, 10% body surface area risk model (ABCD-10) has recently been proposed as an alternative to the SCORe of toxic epidermal necrolysis (SCORTEN) model for predicting in-hospital mortality in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN). In contrast to SCORTEN, ABCD-10 incorporates prior dialysis and upweights the impact of cancer. OBJECTIVE: To determine the performance of ABCD-10 compared with that of SCORTEN in mortality prediction at a large, tertiary burn center. METHODS: A retrospective analysis of 192 patients with SJS/TEN admitted to the North Carolina Jaycee Burn Center from January 1, 2009, to December 31, 2019, was conducted. Data on these patients were collected using the burn registry and a manual chart review. The performance of both the mortality prediction models was assessed using univariate logistic regression and the Hosmer-Lemeshow test. RESULTS: The overall mortality was 22% (n = 43). Nine (5%) patients had cancer, and 7 (4%) had undergone prior dialysis; neither factor was associated with mortality (P = .11 and P = .62, respectively). SCORTEN was well calibrated to predict inpatient mortality (P = .82), whereas ABCD-10 appeared to have a poorer fit (P < .001) in these patients. Both the models showed good discrimination. LIMITATIONS: Small sample size. CONCLUSION: SCORTEN was a better predictor of inpatient mortality than ABCD-10 in a North American cohort of patients treated at the tertiary burn center.
引用
- Duplisea MJ, Roberson ML, Chrisco L, et al. Performance of ABCD-10 and SCORTEN mortality prediction models in a cohort of patients with Stevens-Johnson syndrome/toxic epidermal necrolysis. J Am Acad Dermatol. 2021. PMID: 33940101. doi:10.1016/j.jaad.2021.04.082
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。